Putnam Investments’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-89,171
Closed -$2.58M 1204
2022
Q2
$2.58M Sell
89,171
-32,927
-27% -$1.44M ﹤0.01% 689
2022
Q1
$6.72M Buy
+122,098
New +$6.04M 0.01% 429
2017
Q1
Sell
-114,601
Closed -$1.82M 1283
2016
Q4
$1.82M Buy
114,601
+25,681
+29% +$427K ﹤0.01% 864
2016
Q3
$1.8M Sell
88,920
-44,901
-34% -$825K ﹤0.01% 876
2016
Q2
$2.4M Hold
133,821
0.01% 868
2016
Q1
$1.77M Buy
133,821
+22,784
+21% +$352K ﹤0.01% 982
2015
Q4
$2.27M Buy
+111,037
New +$2.12M 0.01% 944

Other funds holding SGRY

Putnam Investments's SGRY Position: Q3 2022 in Review

Putnam Investments sold out of Surgery Partners (SGRY) in Q3 2022, closing a stake of 89,171 shares — an estimated $2.58M sold.

Putnam Investments first reported a position in SGRY in Q4 2015 and held it in 7 quarters. The position peaked at $6.72M in Q1 2022. 138 funds tracked by Wall St. Rank hold SGRY as of Q3 2022.

  • Putnam Investments reported no remaining Surgery Partners position as of Q3 2022 after selling out during the quarter.
  • Putnam Investments sold 89,171 Surgery Partners shares in Q3 2022, an estimated $2.58M.
  • Putnam Investments first reported a position in Surgery Partners in Q4 2015 and held it in 7 quarters.
  • Putnam Investments's Surgery Partners position peaked at $6.72M in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2022.

Based on Putnam Investments's 13F filing for Q3 2022, filed 14 Nov 2022.